Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toru Miwa

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Scientific Reports|August 22, 2025
Inability of α-cyclodextrins to accommodate cholesterol potentially underlies their lack of efficacy and ototoxicity in Niemann-Pick disease type C treatmentYusei Yamada, Mayuko Tanaka, Yusei Ikeda, et al.
Clinical and Translational Medicine|August 24, 2023
Different solubilizing ability of cyclodextrin derivatives for cholesterol in Niemann-Pick disease type C treatmentYusei Yamada, Madoka Fukaura-Nishizawa, Asami Nishiyama, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 18, 2022
Fine-tuned cholesterol solubilizer, mono-6-O-α-D-maltosyl-γ-cyclodextrin, ameliorates experimental Niemann-Pick disease type C without hearing lossYusei Yamada, Toru Miwa, Masaki Nakashima, et al.
British Journal of Pharmacology|March 30, 2021
Differential mode of cholesterol inclusion with 2-hydroxypropyl-cyclodextrins increases safety margin in treatment of Niemann-Pick disease type CYusei Yamada, Yoichi Ishitsuka, Yuki Kondo, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Scientific Reports|August 22, 2025
Inability of α-cyclodextrins to accommodate cholesterol potentially underlies their lack of efficacy and ototoxicity in Niemann-Pick disease type C treatmentYusei Yamada, Mayuko Tanaka, Yusei Ikeda, et al.
Clinical and Translational Medicine|August 24, 2023
Different solubilizing ability of cyclodextrin derivatives for cholesterol in Niemann-Pick disease type C treatmentYusei Yamada, Madoka Fukaura-Nishizawa, Asami Nishiyama, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 18, 2022
Fine-tuned cholesterol solubilizer, mono-6-O-α-D-maltosyl-γ-cyclodextrin, ameliorates experimental Niemann-Pick disease type C without hearing lossYusei Yamada, Toru Miwa, Masaki Nakashima, et al.
British Journal of Pharmacology|March 30, 2021
Differential mode of cholesterol inclusion with 2-hydroxypropyl-cyclodextrins increases safety margin in treatment of Niemann-Pick disease type CYusei Yamada, Yoichi Ishitsuka, Yuki Kondo, et al.
Pageof 8